The worldwide hyperphosphatemia industry is anticipated to reach a valuation of around USD 12.66 billion in 2023 and grow at a compound annual growth rate (CAGR) of more than 4.8% until 2033. By 2033, ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

When people think of kidney disease, they usually think about problems with how the body removes waste—not about skin issues.

Why Don't Patients Take Their Phosphate Binders? Online survey findings showed significant challenges with compliance to phosphate binder therapy. Among 200 dialysis patients, 37% were non-compliant ...

Additionally, phosphorus binders and electrolyte supplements are an essential part of kidney disease management. High phosphorus levels will speed kidney damage; by using phosphorus-binding agents, ...

BOSTON — Patients on kidney dialysis reported better adherence ... and 126 answered questions about barriers to phosphate binder adherence. Forgetting to take the medication was listed as ...

on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. XPHOZAH offers a different mechanism of ...

While previous studies have identified dialysis vintage as a risk variable for CVC ... lowering medications were not adjusted for in the analysis. Patients on phosphate binders may exhibit suppressed ...